PULMONER VENLER VE ATRİAL FİBRİLASYON
Atrial fibrilasyon (AF), adult yaşlarda yüksek morbidite ve mortaliteye yol açan en sık görülen kalp ritm bozukluğudur. Pulmoner venlerin (PVs) belli şartlarda AF ye neden olabileceğinin tespit edimesini takiben bu durumun nasıl oluştuğunu araştırmaya yönelik bir çok çalışma yapılmıştır. Torasik venler, özellikle PVs elektriksel aktiviteye sahiptir ve bir çok çalışmaya konu olmuştur. PV lerin aritmojenik etkiye yol açması ile ilgili bir çok mekanizma ileri sürülmüştür. PV'lerin kolaylıkla indüklenebilir kardiyomyositler içermesi artmış otomatisite, trigger aktivite başlatma ve mikroentrant çevrim oluşmasına neden olur. Farmakolojik tedavinin çoğu zaman başarısız olması girişimsel tedavilere ilgiyi artırmıştır. Ablasyon teknikleri AF tedavi yönetiminde giderek artan sıklıkta kullanılmaktadır.
PULMONARY VEINS AND ATRIAL FIBRILLATION
Atrial fibrillation (AF) is the most frequent heart rhythm disorder in the adult population, which leads to high morbidity and mortality. The detection that the PVs could be responsible for AF undercertain circumstances has been followed by much research to determine how this can ocur. Thoracic veins, especially the PVs, are electrically active and have been the subject of several studies. Several mechanisms for PV arrhythmogenicity have been proposed. The PVs contained cardiomyocytes with easily inducible arrhythmogenic activity due to the enhanced automaticity, induction of triggered activity, and genesis of microreentrant circuits. The failure of most of the time on pharmacologic treatments has increased interest in interventional treatments. The ablative techniques in managing of AF have be en used with increasing frequency.
___
- 1. Brand FN, Abbott RD, Kannel WB, Wolf PA.
Characteristics and prognosis of lone atrial
fibrillation. 30-y ear follow-up in the Framingham
Study. J Am Med Assoc 1985; 254: 3449-53.
- 2. Levy S, Maarek M, Coumel P, et al. Characterization
of different subsets of atrial fibrillation
in general practice in France: the ALFA
study. The College of French Cardiologists.
Circulation 1999; 99: 3028-35.
- 3. Cheung W. Electrical activity of the pulmonary
vein and its interact›on w›th the right
atrium in the gu›nea-pig. J Physiol 1980; 314:
445-56.
- 4. Haissaguerre M, Jais P, Shah DC, et al.
Spontaneous initiation of atrial fibrillation by
ectopic beats originating in the pulmonary
veins. N Engl J Med 1998; 339: 659-666.
Landmark report that first identified and
demonstrated that ectopic beats originating
from the pulmonary veins initiate clinical
atrial fibrillation.
- 5. Chen SA, Hsieh MH, Tai TC, et al. Initiation
of atrial fibrillation by ectopic beats originating
from the pulmonary veins. Circulation
1999; 100: 1879-86.
- 6. Pappone C, Rosanio S, Oreto G, et al.
Circumferential radiofrequency ablation of
pulmonary vein ostia: a new anatomic
approach. Circulation 2000; 102: 2619-28.
- 7. Oral H, Knight BP, Tada H, et al. Pulmonary
vein isolation for paroxysmal and persistent
atrial fibrillation. Circulation 2002; 105: 1077-81.
- 8. Hirose M, Laurita KR. Calcium-mediated
triggered activity is an underlying cellular
mechanism of ectopy originating from the
pulmonary vein in dogs. Am J Physiol Heart
Circ Physiol 2007; 292: H1861-H1867.
- 9. Patterson E, Po S, Scherlag BJ, Lazzara R.
Triggered firing in pulmonary veins initiated
by in vitro autonomic nerve stimulation.
Heart Rhythm 2005; 2: 624-31.
- 10. Chou C-C, Nihei M, Zhou S, et al. Intracellular
calcium dynamics and anisotropic reentry in
isolated canine pulmonary veins and left
atrium. Circulation 2005;111: 2889-97.
- 11. Arora R, Verheule S, Scott L, et al. Arrhythmogenic
substrate of the pulmonary veins
assessed by high-resolution optical mapping.
Circulation 2003;107: 1816-21.
- 12. Rutger J. Hassink, H. Thomas Aretz, Jeremy
Ruskin, David Keane, Morphology of Atrial
Myocardium in Human Pulmonary Veins A
Postmortem Analysis in Patients With and
Without Atrial Fibrillation J Am Coll Cardiol
2003; 42: 1108-14.
- 13. Jais P, Haissaguerre M, Shah DC, et al. A
focal source of atrialfibrillation treated by
discrete radio frequency ablation. Circulation
1997; 95: 572-6.
- 14. Haissaguerre M, Jais P, Shah DC, et al.
Electrophysiological end pointfor catheter
ablation of atrial fibrillation initiated from
multiple pulmonary venous foci. Circulation
2000; 101: 1409-17.
- 15. Seol CA, Kim J, Kim WT, et al. Simulation of
spontaneous action potentials of cardiomyocytes
in pulmonary veins of rabbits. Prog
Biophys Mol Biol 2008; 96: 132-51.
- 16. Jais P, Haissaguerre M, Shah DC, et al. A
focal source of atrialfibrillation treated by
discrete radio frequency ablation. Circulation
1997; 95: 572-6.
- 17. Ehrlich JR, Cha TJ, Zhang L, et al. Cellular
electrophysiology of canine pulmonary vein
cardiomyocytes: action potential and ionic
current properties. J Physiol 2003; 551:
801-13.
- 18. Coumel P, Attuel P, Lavallee J, Flammang D,
Leclercq JF, Slama R. The atrial arrhythmia
syndrome o f vagal origin. Arch Mal Coeur
Vaiss 1978; 71: 645-56.
- 19. Tan AY, Chen P-S, Chen LS, Fishbein MC.
Autonomic nerves in pulmonary veins. Heart
Rhythm 2007; 4: 57-60.
- 20. Morel E, Meyronet D, Thivolet-Bejuy F,
Chevalier P. Identification and distribution of
interstitial Cajal cells in human pulmonary
veins. Heart Rhythm 2008; 5: 1063-7.
- 21. Chen SA, Hsieh MH, Tai CT, et al. Initiation
of atrial fibrillation by ectopic beats originating
from the pulmonary veins: electrophysiological
characteristics, pharmacological
responses, and effects of radiofrequency
ablation. Circulation 1999; 100: 1879-86.
- 22. Blom NA, Gittenberger-de Groot AC, DeRuiter MC,
et al. Development of the cardiac conduction
tissue in human embryos using HNK-1 antigen
expression: possible relevance for understanding
of abnormal atrial automaticity.
Circulation 1999; 99: 800-6.
- 23. Haissaguerre M, Jais P, Shah DC, et al.
Electrophysiological end pointfor catheter
ablation of atrial fibrillation initiated from
multiple pulmonary venous foci. Circulation
2000; 101: 1409-17.
- 24. Chen YJ, Chen SA, Chen YC, et al. Effects of
rapid atrial pacing on the arrhythmogenic
activity of single cardiomyocytes from
pulmonary veins: implication in initiation of
atrial fibrillation. Circulation 2001; 104:
2849 -54.
- 25. Jais P, Hocini M, Macle L, et al. Distinctive
electrophysiological properties of pulmonary
veins in patients with atrial fibrillation.
Circulation 2002; 106: 2479-85.
- 26. Kumagai K, Ogawa M, Noguchi H, Yasuda T,
Nakashima H & Saku K. Electrophysiologic
properties of pulmonary veins assessed
using a multielectrode basket catheter. J Am
Coll Cardiol 2004; 43: 2281-9.
- 27. Lin WS, Prakash VS, Tai CT, Hsieh MH, Tsai
CF, Yu WC, et al. Pulmonary vein morphology
in patients with paroxysmal atrial fibrillation
initiated by ectopic beats originating from
the pulmonary veins: implications for
catheter ablation. Circulation 2000; 101:
1274-81.
- 28. Herweg B, Sichrovsk, T, Polosajian L,
Rozenshtein A & Steinberg JS. Hypertension
and hypertensive heart disease are associated
with increased ostial pulmonary vein diameter.
J Cardiovasc Electrophysiol 2005; 16: 2-5.
- 29. Pan NH, Tsao HM, Chang NC, Chen YJ & Chen
SA. Aging dilates atrium and pulmonary
veins: implications for the genesis of atrial
fibrillation. Chest 2008; 133: 190-6.
- 30. Chang SL, Chen YC, Chen YJ, Wangcharoen,
W, Lee SH, Lin CI, et al. Mechanoelectrical
feedback regulates the arrhythmogenic
activity of pulmonary veins. Heart 2007; 93:
82-8.
- 31. Seol CA., Kim WT, Ha JM, Choe H, Jang YJ,
Youm JB, et al. Stretchactivated currents in
cardiomyocytes isolated from rabbit pulmonary
veins. Prog Biophys Mol Biol 2008; 97:
217-31.
- 32. Maruyama T, Kishikawa T, Ito H, Kaji Y,
Sasaki Y & Ishihara Y. Augmentation of
pulmonary vein backflow velocity during left
atrial contraction: a novel phenomenon
responsible for progression of atrial fibrillation
in hypertensive patients. Cardiology
2008; 109: 33-40. Cardiovasc Electrophysiol
16: 2-5.
- 33. Chiu YT, Wu TJ, Wei HJ, Cheng CC, Lin NN,
Chen YT, et al. Increased extracellular collagen
matrix in myocardial sleeves of pulmonary
veins: an additional mechanism facilitating
repetitive rapid activities in chronic
pacinginduced sustained atrial fibrillation.
J Cardiovasc Electrophysiol 2005; 16: 753-9.
- 34. Tabata T, Thomas JD & Klein AL. Pulmonary
venous flow by Doppler echocardiography:
revisited 12 years later. J Am Coll Cardiol
2003; 41: 1243-50.
- 35. Tsao HM, Yu WC, Cheng HC, Wu MH, Tai CT,
Lin WS, et al. Pulmonary vein dilation in
patients with atrial fibrillation: detection by
magnetic resonance imaging. J Cardiovasc
Electrophysiol 2001; 12(7): 809-13.
- 36. Chen SA, Chen YJ, Yeh HI, Tai CT, Chen YC,
Lin CI.Pathophysiology of the pulmonary
vein as an atrial fibrillation initiator. Pacing
Clin Electrophysiol 2003; 26: 1576-82.
- 37. Blom NA, Gittenberger-de Groot AC, DeRuiter MC,
Poelmann RE, Mentink MM, Ottenkamp J.
Development of the cardiac conduction tissue
in human embryos using HNK-1 antigen
expression: possible relevance for understanding
of abnormal atrial automaticity.
Circulation 1999; 99: 800-6.
- 38. Arora R, Verheule S, Scott L, et al. Arrhythmogenic
substrate of the pulmonary veins
assessed by high-resolution optical mapping.
Circulation 2003; 107: 1816-21.
- 39. Eva Hertervig, Ole Kongstad, Erik Ljungstrom,
Bertil Olsson, and Shiwen Yuan Pulmonary
vein potentials in patients with and without
atrial fibrillation Europace 2008; 10: 692-7l.
- 40. Coumel P. Paroxysmal atrial fibrillation: a
disorder of autonomic tone? Eur Heart J
1994; 15: 916.
- 41. Oral H, Chugh A, Scharf C, et al. Pulmonary
vein isolation for vagotonic, adrenergic, and
random episodes of paroxysmal atrial
fibrillation. J Cardiovasc Electrophysiol 2004;
15: 402-8.
- 42. Pappone C, Santinelli V, Manguso F, et al.
Pulmonary vein denervation enhances longterm
benefit AFter circumferential ablation
for paroxysmal atrial fibrillation. Circulation
2004; 109: 327-34.
- 43. Lemola K, Chartier D, Yeh YH, et al. Pulmonary
vein region ablation in experimental
vagal atrial fibrillation: role of pulmonary
veins versus autonomic ganglia. Circulation
2008; 117: 470-7.
- 44. Armour JA, Murphy DA, Yuan BX, Macdonald
S & Hopkins DA. Gross and microscopic
anatomy of the human intrinsic cardiac
nervous system. Anat Rec 1997; 247: 289.
- 45. Tan AY, Li H, Wachsmann-Hogiu S, Chen LS,
Chen PS & Fishbein MC. Autonomic innervation
and segmental muscular disconnections
at the human pulmonary vein–atrial
junction: implications for catheter ablation
of atrial–pulmonary vein junction. J Am Coll
Cardiol 2006; 48: 132-43.
- 46. Tan AY, Zhou S, Jung BC, Ogawa M, Chen
LS, Fishbein MC, et al. Ectopicatrial arrhythmias
arising from canine thoracic veins
during in-vivo stellate ganglia stimulation.
Am J Physiol Heart Circ Physiol 2008; 259:
691-8.
- 47. Oral H, Chugh A, Scharf C, Hall B, Che ung P,
Veerareddy S, et al. Pulmonary vein isolation
for vagotonic, adrenergic,and random episodes
of paroxysmal atrial fibrillation. J Cardiovasc
Electrophysiol 2004; 15(4): 402-6.
- 48. Chen SA, Chen YJ, Yeh HI, Tai CT, Chen YC,
Lin CI.Pathophysiology of the pulmonary
vein as an atrial fibrillation initiator. Pacing
Clin Electrophysiol 2003; 26: 1576-82.
- 49. Oral H, Ozaydin M, Chugh A, Scharf C, Tada
H, Hall B, et al. Role of the coronary sinus in
maintenance of atrial fibrillation. J Cardiovasc
Electrophysiol 2003;14(12): 1329-36.
- 50 Lin YJ, Tai CT, Kao T, Tso HW, Higa S, Tsao
HM, et al. Frequency analysis in different
types of paroxysmal atrial fibrillation. J Am
Coll Cardiol 2006; 47(7): 1401-7.
- 51. Chen YC, Chen SA, Chen YJ, Chang MS,
Chan P, Lin CI.Effects of thyroid hormone on
the arrhythmogenic activityof pulmonary vein
cardiomyocytes. J Am Coll Cardiol 2002;
39(2): 366-72.
- 52. Jais P, Haissaguerre M, Shah DC, et al. A
focal source of atrial fibrillation treated by
discrete radio frequency ablation. Circulation
1997; 95: 572-6.
- 53. Vickas V Patel. Novel insights into the
cellular basis of atrial fibrillation. Expert Rev
Cardiovasc Ther 2010; 8(7): 907-16.
- 54. Blom NA, Gittenberger-de Groot AC, DeRuiter
MC, Poelmann RE, Mentink MM, Ottenkamp
J. Development of the cardiac conduction
tissue in human embryos using HNK-1
antigen expression: possible relevance for
understanding of abnormal atrial automaticity.
Circulation 1999; 99: 800-6.
- 55. Masani F. Node-like cells in the myocardial
layer of the pulmonary vein of rats: an
ultrastructural study. J Anat 1986; 145: 133-42.
- 56. Perez-Lugones A, McMahon JT, Ratliff NB,
Saliba WI, Schweikert RA, Marrouche NF, et
al. Evidence of specialized conduction cells
in human pulmonary veins of patients with
atrial fibrillation. J Cardiovasc Electrophysiol
2003; 14(8): 803-9.
- 57. Roux N, Havet E & Mertl P. The myocardial
sleeves of the pulmonary veins:potential
implications for atrial fibrillation. Surg Radiol
Anat 2004; 26: 285-9.
- 58. Mueller-Hoecker J, Beitinger F, Fernandez B,
Bahlmann O, Assmann G, Troidl C, et al. Of
rodents and humans: a light microscopic
and ultrastructural study on cardiomyocytes
in pulmonary veins. Int J Med Sci 2008; 5:
152-8.
- 59. Verheule S, Wilson EE, Arora R, et al. Tissue
structure and connexin expression of canine
pulmonary veins. Cardiovasc Res 2002; 55:
727-38.
- 60. Narayan SM, Kazi D, Krummen DE, et al.
Repolarization and activation restitution
near human pulmonary veins and atrial
fibrillation initiation: a mechanism for the
initiation of atrial fibrillation by premature
beats. J Am Coll Cardiol 2008; 52: 1222-30.
- 61. Lutomsky BA, Rostock T, Koops A, Steven D,
Müllerleile K, Servatius H, et al. Catheter
ablation of paroxysmal atrial fibrillation
improves cardiac function: a prospective
study on the impact of atrial fibrillation
ablation on left ventricularfunction assessed
by magnetic resonance imaging. Europace
2008; 10: 593-9.
- 62. Okuyama Y, Miyauchi Y, Park AM, Hamabe
A, Zhou S, Hayashi H, et al. High resolution
mapping of the pulmonary vein and the vein
of Marshall during induced atrial fibrillation
and atrial tachycardia in a canine model of
pacinginduced congestive heart failure. J
Am Coll Cardiol 2003; 42: 348-60.
- 63. Sun Q, Tang M, Pu J & Zhang S. Pulmonary
venous structural remodeling in a canine
model of chronic atrial dilation due to mitral
regurgitation. Can J Cardiol 2003; 24: 305-8.
- 64. Wetzel U, Boldt A, Lauschke J, Weigl J,
Schirdewahn P, Dorszewski A, et al. Expression
of connexins 40 and 43 in human left
atrium in atrial fibrillation of different
aetiologies. Heart 2005; 91: 166-70.
- 65. Chen YC, Chen SA, Chen YJ, Chang MS,
Chan P & Lin CI. Effects of thyroid hormone
on the arrhythmogenic activity of pulmonary
vein cardiomyocytes. J Am Coll Cardiol
2002; 39: 366-72.
- 66. Siyamek Neragi-Miandoaba, Shoshana Weinerb,
David J. Sugarbaker Incidence of atrial
fibrillation AFter extrapleural pneumonectomy
vs. pleurec tomy in patients with malignant
pleural mesothelioma Interactive Cardio
Vascular and Thoracic Surgery 2008; 7:
1039-43.
- 67. Chen SA, Hsieh MH, Tai CT, et al. Initiation
of atrial fibrillation by ectopic beats originating
from the pulmonary veins: electrophysiological
characteristics, pharmacological responses,
and effects of radiofrequency ablation.
Circulation 1999; 100: 1879-86.
- 68. Patterson E, Lazzara R, Szabo B, et al.
Sodium-calcium exchange initiated by the
Ca2_ transient: an arrhythmia trigger within
pulmonary veins. J Am Coll Cardiol 2006;
47: 1196-206.
- 69. Patterson E, Po SS, Scherlag BJ, et al.
Triggered firing in pulmonary veins initiated
by in vitro autonomic nerve stimulation.
Heart Rhythm 2005; 2: 624-31.
- 70. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS,
Yu WC, et al. Initiation of atrial fibrillation by
ectopic beats originating from the pulmonaryveins:
electrophysiological characteristics,
pharmacological responses, and effects of
radiofrequency ablation. Circulation 1999;
100: 1879-86.
- 71. Chen YJ, Chen YC, Tai CT, Yeh HI, Lin CI &
Chen SA. Angiotensin II and angiotensin II
receptor blocker modulate the arrhythmogenic
activity of pulmonaryveins. Br J Pharmacol
2006; 147: 12-22.
- 72. Chen YJ, Chen YC, Wongcharoen W, Lin CI,
& Chen SA. Effect of K201, anovel antiarrhythmic
drug on calcium handling and
arrhythmogenic activity of pulmonary vein
cardiomyocytes. Br J Pharmacol 2008; 153:
915-25.
- 73. Sicouri S, Glass A, Belardinelli L & Antzelevitch
C. Antiarrhythmic effects of ranolazine in
canine pulmonary vein sleeve preparations.
Heart Rhythm 2008; 5: 1019-26.
- 74. Rostock T, Servatius H, Risius T, Ventura R,
Weiss C, Meinertz T, et al. Impact of amiodarone
on electrophysiologic properties of
pulmonary veins in patients with paroxysmal
atrial fibrillation. J Cardiovasc Electrophysiol
2005; 16: 39-44.
- 75. Tojo H, Kumagai K, Noguchi H, Ogawa M,
Yasuda T, Nakashima H, et al. Hybrid
therapy with pilsicainide and pulmonary vein
isolation for atrial fibrillation. Circ J 2005;
69: 1503-7.
- 76. Haissaguerre M, Shah DC, Jaïs P, Hocini M,
Yamane T, Deisenhofer I, et al. Electrophysiological
breakthroughs from the left
atrium to the pulmonary veins. Circulation
2000; 102: 2463-5.
- 77. Oral H, Knight BP, Tada H, Ozaydin M,
Chugh A, Hassan S, et al. Pulmonary vein
isolation for paroxysmal and persistent atrial
fibrillation. Circulation 2002; 105: 1077-81.
- 78. Tojo H, Kumagai K, Noguchi H, Ogawa M,
Yasuda T, Nakashima H, et al. Hybrid
therapy with pilsicainide and pulmonary vein
isolation for atrial fibrillation. Circ J 2005;
69: 1503-7.